BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15668862)

  • 1. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases.
    Yoo JH; Choi JH; Choi SM; Lee DG; Shin WS; Min WS; Kim CC
    Clin Infect Dis; 2005 Feb; 40(3):392-8. PubMed ID: 15668862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders.
    Suankratay C; Kanitcharaskul P; Arunyingmongkol K
    J Med Assoc Thai; 2006 Nov; 89(11):1851-8. PubMed ID: 17205865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis.
    Lai CC; Hsu HL; Lee LN; Hsueh PR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):148-53. PubMed ID: 17446963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the real-time nucleic acid sequence-based amplification (RTi-NASBA) with conventional NASBA, and galactomannan assay for the diagnosis of invasive aspergillosis.
    Yoo JH; Choi SM; Lee DG; Park SH; Choi JH; Kwon EY; Shin WS
    J Korean Med Sci; 2007 Aug; 22(4):672-6. PubMed ID: 17728508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
    Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
    Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
    Husain S; Paterson DL; Studer SM; Crespo M; Pilewski J; Durkin M; Wheat JL; Johnson B; McLaughlin L; Bentsen C; McCurry KR; Singh N
    Transplantation; 2007 May; 83(10):1330-6. PubMed ID: 17519782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay.
    Maertens JA; Klont R; Masson C; Theunissen K; Meersseman W; Lagrou K; Heinen C; Crépin B; Van Eldere J; Tabouret M; Donnelly JP; Verweij PE
    Clin Infect Dis; 2007 May; 44(10):1329-36. PubMed ID: 17443470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
    Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
    Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
    Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
    Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
    Xie LP; Liu T; Meng WT; Zhou J
    Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
    Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
    Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
    White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
    Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
    Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
    Maertens J; Maertens V; Theunissen K; Meersseman W; Meersseman P; Meers S; Verbeken E; Verhoef G; Van Eldere J; Lagrou K
    Clin Infect Dis; 2009 Dec; 49(11):1688-93. PubMed ID: 19886801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
    Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
    Ruchlemer R; Yinnon AM; Hershko C
    Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.